Search Results 341-350 of 17416 for alopecia

1. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) - Mayo Clinic

   ... alopecia and the criteria outlined; Patients must not have any history of cancer within 5 years from randomization, with the exception of in-situ carcinomas ...

2. Massage Therapy at Mayo Clinic

   Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

3. A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer - Mayo Clinic

   ... alopecia, radiation tissue fibrosis, or peripheral neuropathy) * Known allergies, hypersensitivity, or intolerance to JNJ-69086420 or its excipients and ...

4. Oral lichen planus - Symptoms and causes - Mayo Clinic

   This ongoing inflammatory condition results in white, lacy patches or red, swollen tissues or open sores inside your mouth that may cause burning or pain.

5. Hypoparathyroidism - Symptoms & causes - Mayo Clinic

   Learn more about this condition in which low levels of parathyroid hormone upset the balance of calcium and phosphorus in the body.

6. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Exceptions: Neuropathy, fatigue, and/or alopecia may be grade 1. Known active central nervous system (CNS) metastases. NOTE: Patients with previously ...

7. A Study to Evaluate T-DM1 With or Without Abemaciclib in Women and Men with HER2-positive Advanced or Metastatic Breast Cancer - Mayo Clinic

   NOTE: All residual toxicities (except alopecia) should be at baseline or grade 1 (including peripheral neuropathy). NOTE: If indicated, patients can ...

8. Alternative medicine

   Transcutaneous electrical nerve stimulation. A device placed on the skin sends low-voltage electrical currents to the painful area. Stress tends to make ...

9. A Study To Investigate The Safety And Tolerability Of Ziftomenib In Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, Or 7+3+Quizartinib In Patients With AML - Mayo Clinic

   ... alopecia * Known clinically active human immunodeficiency virus, active hepatitis B or active hepatitis C infection * For newly diagnosed cohorts: received ...

10. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

    due to prior treatments, excluding alopecia and Grade 2 neuropathy. Exclusion Criteria: The presence of any of the following will exclude a subject from ...